Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

The Lead

Pharmaceutical Trade Association: Greek Medicine Supply May Be At Risk

June 30, 2015 | by Ryan Bushey, Associate Editor | Articles | Comments

The organization is calling for the European Union to take emergency action. Read more...

View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Novartis to Try Novel Pricing Strategy for Heart Failure Drug

June 30, 2015 4:39 pm | by Ryan Bushey, Associate Editor | Articles | Comments

The company is treading in establishing the exact cost per pill. Read more...


BiondVax Announces Positive Preliminary Phase 2 Results for Universal Flu Vaccine

June 30, 2015 4:28 pm | News | Comments

These results support BiondVax’s claim that M-001 provides a broaden and improved coverage against multiple influenza type A and B virus strains. Read more...


Research Reveals New Insights into Key Antibiotic Target in Fight Against TB

June 30, 2015 4:19 pm | by University of Sussex | News | Comments

While TB is curable, antibiotic resistance is on the rise and so a major challenge for scientists is to continually develop new drugs to treat the disease. Read more...


Liberia Quarantines an Area Where New Ebola Case Appeared

June 30, 2015 4:11 pm | by Jonathan Paye-Layleh, Associated Press | News | Comments

The World Health Organization declared Liberia Ebola-free on May 9, after it went 42 days without a new case. Read more...


The Leukemia & Lymphoma Society Accelerates Payment Linked to Phase 3 AML Study

June 30, 2015 12:24 pm | by The Leukemia & Lymphoma Society | News | Comments

Celator Pharmaceuticals, Inc. today announced that The Leukemia & Lymphoma Society (LLS) is accelerating a portion of the final payment linked to the Phase 3 study of CPX-351 (cytarabine:daunorubicin) liposome injection, Celator's lead product candidate, for the treatment of patients with high-risk (secondary) acute myeloid leukemia (AML). Read more...


National Study Finds Life-Threatening Barriers in Access to Breakthrough Drugs

June 30, 2015 12:16 pm | by Lifespan | News | Comments

Most states violate federal Medicaid law because they deny coverage for sofosbuvir, a new and highly effective treatment to cure hepatitis C, according to Lynn E. Taylor, M.D., director of The Miriam Hospital's HIV/Viral Hepatitis Coinfection Program.  Read more...


Treatment With PI3K Inhibitors May Cause Cancers to Become Aggressive, Metastatic

June 30, 2015 11:43 am | by The Wistar Institute | News | Comments

The enzyme phosphatidylinositol-3 kinase (PI3K) appears to be exploited in almost every type of human cancer, making it the focus of considerable interest as a therapeutic target, with many PI3K-inhibiting drugs currently in various stages of clinical development.  Read more...


Regeneron's Retinal Vein Occlusion Treatment Receives Approval in Japan

June 30, 2015 8:39 am | News | Comments

This new indication includes macular edema secondary to branch retinal vein occlusion in addition to the previously-approved indication of macular edema secondary to central retinal vein occlusion. Read more...


Global Biosimilars Market Value Could Hit $55B by 2020

June 30, 2015 8:28 am | by Sumith Ladda, Analyst, GBI Research | Articles | Comments

The 30 percent to 50 percent reduction in biosimilar prices compared with branded biologics could lead to considerable savings in healthcare expenditure. Read more...


CHMP Recommends EU Approval for Novartis' Multiple Myeloma Treatment

June 30, 2015 8:18 am | News | Comments

Multiple myeloma is a cancer of the plasma cells, a type of white blood cell present in the bone marrow, and affects approximately 84,000 people in Europe. Read more...


New Study Verifies Accuracy of Rapid Ebola Test

June 30, 2015 8:18 am | by Tulane University | News | Comments

The study results confirm that the test can be used in the field and deliver a high level of accuracy. Read more...


Multi-Million-Dollar Deal Brings UQ Pain Drug Closer to Reality

June 30, 2015 8:18 am | by University of Queensland | News | Comments

A chronic pain treatment discovered at The University of Queensland is a step closer to clinical use. Read more...


Conn. Nurse Pleads Guilty to Prescribing Pain Meds for Drug-Company Kickbacks

June 29, 2015 11:56 am | by Seth Augenstein, Digital Reporter | News | Comments

A nurse admitted in federal court to prescribing pain medications in exchange for kickbacks from a drug company, according to authorities. Read more...


Lilly, Immunocore: Immunotherapy-based Clinical Trial Collaboration in Melanoma

June 29, 2015 9:48 am | News | Comments

Eli Lilly and Company and Immunocore Limited today announced that they have entered into an immunotherapy-based clinical trial collaboration to explore the utility of Immunocore's lead T cell receptor-based investigational therapeutic, IMCgp100, in combination with Lilly's galunisertib (LY2157299) and merestinib (LY2801653) for the treatment of melanoma. Read more...


Scientists Look Into Why Most Alzheimer's Patients Are Women

June 29, 2015 9:42 am | by Lauren Neergaard, AP Medical writer - Associated Press | News | Comments

Nearly two-thirds of Americans with Alzheimer's disease are women, and now some scientists are questioning the long-held assumption that it's just because they tend to live longer than men. Read more..



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.